Greenbrook TMS Therapy and Esketamine: Summary

Greenbrook TMS Therapy and Esketamine

Healthcare, Mental Health, Depression Treatment, Non-Medication Therapy

Greenbrook provides effective, non-drug treatments for depression, offering hope to those who have not found success with traditional therapies.

Greenbrook offers innovative treatments for depression, specializing in Transcranial Magnetic Stimulation (TMS) therapy and Spravato (esketamine). These options are designed for individuals who have not found relief through traditional antidepressants and talk therapy.

FDA-cleared, non-medication depression treatment (NeuroStar TMS Therapy); FDA-approved, ketamine-based treatment (Spravato); Non-invasive with no drug-related side effects; Covered by most insurance plans, including Medicare and Medicaid

Greenbrook's services are most valuable for individuals struggling with treatment-resistant depression, those who have experienced side effects from traditional medications, and patients seeking non-drug alternatives.

Non-invasive treatments with minimal side effects compared to traditional medications; Comprehensive support with insurance claims and paperwork; Flexible treatment options that can complement existing medication regimens

Greenbrook's strengths lie in its specialized focus on depression, the effectiveness of its treatments, and its commitment to patient support throughout the treatment process.

Greenbrook positions itself as a leader in innovative depression treatments, emphasizing non-invasive and effective options for patients who have not responded to traditional therapies.

The target users include individuals suffering from depression, particularly those who have not found relief through conventional treatments, as well as their families seeking effective solutions.

Schedule a No-Cost Consultation

• TMS Therapy

• Esketamine

• Depression Treatment

• Mental Health

You can feel better. We're the depression specialists.

Supportive, professional, empathetic

Greenbrook uniquely combines FDA-cleared TMS therapy and FDA-approved Spravato, focusing on non-invasive treatments that specifically target brain areas associated with depression.

Greenbrook identifies itself as a compassionate and specialized provider of mental health treatments, focusing on patient care and innovative solutions for depression.

2011-01-01

• William P. Leonard